Oyler, Douglas R.
Westgate, Philip M.
Walsh, Sharon L.
Dolly Prothro, Jennifer
Miller, Craig S.
Roberts, Monica F.
Freeman, Patricia R.
Knudsen, Hannah K.
Lang, Maggie
Dominguez-Fernandez, Enif
Rojas-Ramirez, Marcia V.
Funding for this research was provided by:
National Institutes of Health (4UH3DE032621, 4UH3DE032621, 4UH3DE032621, 4UH3DE032621, 4UH3DE032621, 4UH3DE032621, 4UH3DE032621, 4UH3DE032621, 4UH3DE032621, 4UH3DE032621, 4UH3DE032621)
Article History
Received: 22 February 2024
Accepted: 28 March 2024
First Online: 4 April 2024
Declarations
:
: This protocol has been reviewed and approved by the UK Medical Institutional Review Board (IRB) under protocol number 80758. Provider participants will provide full informed consent prior to participation. Patient participants (survey respondents) will acknowledge review of a cover letter in lieu of full informed consent, and the parental permission requirement has been waived by the IRB. A waiver of informed consent has been granted by the IRB for EHR review. Protocol modifications require prior approval from the IRB and notification of the sponsor/medical monitor prior to implementation.
: Not applicable.
: The authors declare no competing interests.